Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleThe State of the Art
Open Access

Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy

Jeremie Calais, Michael J. Morris, Ayse Tuba Kendi, Arash Rezazadeh Kalebasty, Ronald Tutrone, Michael J. Anderson and Oliver Sartor
Journal of Nuclear Medicine November 2024, 65 (11) 1666-1671; DOI: https://doi.org/10.2967/jnumed.124.268363
Jeremie Calais
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Morris
2Department of Genitourinary Oncology, Memorial Sloan Kettering Cancer Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayse Tuba Kendi
3Department of Radiology, Mayo Clinic, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arash Rezazadeh Kalebasty
4School of Medicine, University of California, Irvine, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald Tutrone
5Chesapeake Urology Research Associates, Towson, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Anderson
6Department of Radiation Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Sartor
7Departments of Urology and Oncology, Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Additional Files

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (11)
Journal of Nuclear Medicine
Vol. 65, Issue 11
November 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
Jeremie Calais, Michael J. Morris, Ayse Tuba Kendi, Arash Rezazadeh Kalebasty, Ronald Tutrone, Michael J. Anderson, Oliver Sartor
Journal of Nuclear Medicine Nov 2024, 65 (11) 1666-1671; DOI: 10.2967/jnumed.124.268363

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
Jeremie Calais, Michael J. Morris, Ayse Tuba Kendi, Arash Rezazadeh Kalebasty, Ronald Tutrone, Michael J. Anderson, Oliver Sartor
Journal of Nuclear Medicine Nov 2024, 65 (11) 1666-1671; DOI: 10.2967/jnumed.124.268363
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • BEST PRACTICES FOR AE MANAGEMENT
    • BEST PRACTICES FOR RADIATION SAFETY IN PSMA-TARGETED AGENTS
    • BEST PRACTICES FOR MULTIDISCIPLINARY MANAGEMENT OF MCRPC DURING PSMA-TARGETED RPT
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy
  • Rethinking Dosimetry: A European Perspective
  • A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry
Show more The State of the Art

Similar Articles

Keywords

  • metastatic castration-resistant prostate cancer
  • prostate-specific membrane antigen
  • radiopharmaceutical therapy
  • multidisciplinary management
  • adverse events
SNMMI

© 2025 SNMMI

Powered by HighWire